Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Klein, A. Pekosz, Han-sol Park, R. Ursin, J. Shapiro, Sarah Benner, K. Littlefield, Swetha Kumar, Harnish Naik, M. Betenbaugh, R. Shrestha, Annie Wu, Robert Hughes, Imani Burgess, P. Caturegli, O. Laeyendecker, T. Quinn, D. Sullivan, S. Shoham, A. Redd, E. Bloch, A. Casadevall, A. Tobian (2020)
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population.The Journal of clinical investigation
E. Walsh, R. Frenck, A. Falsey, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, K. Neuzil, M. Mulligan, R. Bailey, K. Swanson, Ping Li, K. Koury, W. Kalina, D. Cooper, Camila Fontes-Garfias, P. Shi, Ö. Türeci, Kristin Tompkins, K. Lyke, V. Raabe, P. Dormitzer, K. Jansen, U. Şahin, W. Gruber (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesThe New England Journal of Medicine
B. Boyarsky, William Werbel, R. Avery, A. Tobian, A. Massie, D. Segev, J. Garonzik‐Wang (2021)
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.JAMA
L. Jackson, E. Anderson, N. Rouphael, P. Roberts, M. Makhene, R. Coler, M. McCullough, J. Chappell, M. Denison, Laura Stevens, A. Pruijssers, A. McDermott, B. Flach, N. Doria-Rose, Kizzmekia Corbett, Kaitlyn Morabito, S. O'dell, S. Schmidt, P. Swanson, M. Padilla, J. Mascola, K. Neuzil, H. Bennett, Wellington Sun, E. Peters, M. Makowski, J. Albert, Kaitlyn Cross, Wendy Buchanan, Rhonda Pikaart-Tautges, J. Ledgerwood, B. Graham, J. Beigel (2020)
An mRNA Vaccine against SARS-CoV-2 — Preliminary ReportThe New England Journal of Medicine
E. Patel, E. Bloch, W. Clarke, Y. Hsieh, D. Boon, Y. Eby, R. Fernandez, O. Baker, Morgan Keruly, C. Kirby, E. Klock, K. Littlefield, Jernelle Miller, Haley Schmidt, P. Sullivan, E. Piwowar-Manning, R. Shrestha, A. Redd, R. Rothman, D. Sullivan, S. Shoham, A. Casadevall, T. Quinn, A. Pekosz, A. Tobian, O. Laeyendecker (2020)
Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titersmedRxiv
T. Mueller (2021)
Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturerClinica Chimica Acta; International Journal of Clinical Chemistry, 518
This follow-up study measures the antibody response following the second dose of SARS-CoV-2 mRNA vaccine in recipients of solid organ transplants.
JAMA – American Medical Association
Published: Jun 1, 2021
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.